Siga Technologies (SIGA) Depreciation & Amortization (CF) (2010 - 2025)
Siga Technologies (SIGA) reported Depreciation & Amortization (CF) of $100000.0 for Q3 2025, down 22.11% on a YoY basis from $128382.0 in Q3 2024, and down 50.0% quarter-over-quarter from $200000.0 in Q2 2025.
Siga Technologies (SIGA) Depreciation & Amortization (CF) (2010 - 2025) Analysis & Trends
Siga Technologies has reported Depreciation & Amortization (CF) for 16 years, with the latest figure at $100000.0 in Q3 2025.
- For the quarter ending Q3 2025, Depreciation & Amortization (CF) fell 22.11% year-over-year to $100000.0; the trailing twelve-month figure through Dec 2025 stood at $400000.0 (down 20.0% YoY), and the FY2024 full-year result was $500000.0, down 7.11% from the prior year.
- Depreciation & Amortization (CF) for Q3 2025 stood at $100000.0, down from $200000.0 in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $200000.0 in Q2 2023, with the low at $92308.0 in Q4 2024.
- Historically, Depreciation & Amortization (CF) has averaged $129259.8 across 5 years, with a median of $128382.0 in 2024.
- Annual changes were most pronounced in 2021 — Depreciation & Amortization (CF) climbed 28.83% — and 2024, when it slumped 33.25%.
- Siga Technologies' Depreciation & Amortization (CF) stood at $106333.0 in 2021, then grew by 23.39% to $131203.0 in 2022, then climbed by 5.4% to $138293.0 in 2023, then tumbled by 33.25% to $92308.0 in 2024, then rose by 8.33% to $100000.0 in 2025.
- The last three Depreciation & Amortization (CF) figures came in at $100000.0 (Q3 2025), $200000.0 (Q2 2025), and $100000.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 239.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 119.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 22.60 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 7.20 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 172.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 19.43 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 22.68 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 21.95 Mn |
| 10 | Siga Technologies | 310.79 Mn | 155.83 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 100,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 200,000.00 |
| Jun 30, 2025 | 200,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Dec 31, 2024 | 92,308.00 |
| Dec 31, 2024 | 92,308.00 |
| Sep 30, 2024 | 128,382.00 |
| Sep 30, 2024 | 128,382.00 |
| Jun 30, 2024 | 179,310.00 |
| Jun 30, 2024 | 179,310.00 |
| Mar 31, 2024 | 100,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Dec 31, 2023 | 138,293.00 |
| Dec 31, 2023 | 138,293.00 |
| Sep 30, 2023 | 100,000.00 |
| Sep 30, 2023 | 100,000.00 |
| Jun 30, 2023 | 200,000.00 |
| Jun 30, 2023 | 200,000.00 |